Frank Lovering - Concepedia

Author

Frank Lovering

Pfizer (United States)ORCID

Also Known As

F. E. LOVERING, F. Lovering, F.E. Lovering, Frank E. Lovering, Frank Lovering, Lovering, Frank E.

Publications

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)Pearl River Community College Inflammation Research Foundation Princeton University University of Michigan

About

Frank Lovering is an author at Pfizer (United States) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	21	2.1K
2	Biochemistry	13	15	1.9K
3	Natural Sciences	11	14	472
4	Engineering	2	2	1.4K
5	Cell Biology	2	2	48

Frank Lovering

Publications

6.9K

Citations

H-Index

Page 1

	Year	Citations
Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success Frank Lovering, Jack Bikker, Christine Humblet Journal of Medicinal Chemistry	2009	4.2K
Escape from Flatland 2: complexity and promiscuity Frank Lovering MedChemComm Computational Complexity TheoryEngineeringMolecular BiologyComputational ComplexityFlatland 2	2012	1.3K
Discovery of PF-06928215 as a high affinity inhibitor of cGAS enabled by a novel fluorescence polarization assay J. Perry Hall, Amy Brault, Fabien Vincent, PLoS ONE	2017	157
Fluorine in Drug Design: A Case Study with Fluoroanisoles Xing Li, David C. Blakemore, Arjun Narayanan, ChemMedChem	2015	148
Discovery of Clinical Candidate 1-{[(2 <i>S</i> ,3 <i>S</i> ,4 <i>S</i> )-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based Drug Design Katherine L. Lee, Catherine M. Ambler, David R. Anderson, Journal of Medicinal Chemistry	2017	138
Acylguanidines as Small-Molecule β-Secretase Inhibitors Derek C. Cole, Eric S. Manas, Joseph R. Stock, Journal of Medicinal Chemistry Protein AssemblyMolecular BiologyAmyloid Precursor ProteinChemical BiologyPharmaceutical Chemistry	2006	100
Inhibition of Cytosolic Phospholipase A<sub>2</sub>α: Hit to Lead Optimization John C. McKew, Megan A. Foley, Paresh Thakker, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryInhibitory ActivityPharmaceutical ScienceBiochemistry	2005	76
Identification of potent and selective MMP-13 inhibitors Junjun Wu, Thomas S. Rush, Rajeev Hotchandani, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryMedicineSelective Mmp-13 InhibitorsPharmacotherapyAnti-cancer Agent	2005	70
Conformationally restricted inhibitors of the high affinity -glutamate transporter Richard J. Bridges, Frank Lovering, John M. Humphrey, Bioorganic & Medicinal Chemistry Letters BiochemistryMedicineMechanism Of ActionConformational StudyPharmacology	1993	58
Millisecond dynamics of BTK reveal kinome-wide conformational plasticity within the apo kinase domain Mohammad M. Sultan, R. Aldrin Denny, Ray Unwalla, Scientific Reports EngineeringApo Kinase DomainMillisecond DynamicsMolecular BiologyComputational Chemistry	2017	50

Page 1